Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients
Condition:   Celiac Disease Interventions:   Drug: DONQ52;   Drug: Placebo Sponsor:   Chugai Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2022 Category: Research Source Type: clinical trials

A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
Condition:   Celiac Disease Interventions:   Drug: TAK-062;   Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar;   Drug: TAK-062 Placebo;   Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2022 Category: Research Source Type: clinical trials